Clinical Trials Directory

Trials / Completed

CompletedNCT06437262

Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva

Randomized Clinical Trial on the Immediate Antibacterial Effect and Substantivity of a Single Application of a New Chlorhexidine Gel on Oral Biofilm and Saliva

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Santiago de Compostela · Academic / Other
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this project was to compare the immediate antimicrobial effect and in situ substantivity of a new 0.20% chlorhexidine (CHX) gel and cymenol with the current CHX gel formulation on dental plaque biofilm and salivary flora up to 7 hours after a single application.

Conditions

Interventions

TypeNameDescription
DRUG0.20% CHX gel on salivaIn vivo application of a gel on the vestibular and palatal/lingual gingival mucosa of both arches at minute 0 for posterior saliva collection at different time-points.
DRUG0.20% CHX and Cymenol gel on salivaIn vivo application of a gel on the vestibular and palatal/lingual gingival mucosa of both arches at minute 0 for posterior saliva collection at different time-points.
DRUG0.20% CHX gel on oral biofilmEx vivo application of a gel on the glass disks of the removable intraoral appliance at minute 0 for subsequent one-by-one disk removal from the device at different time-points.
DRUG0.20% CHX and Cymenol gel on oral biofilmEx vivo application of a gel on the glass disks of the removable intraoral appliance at minute 0 for subsequent one-by-one disk removal from the device at different time-points.

Timeline

Start date
2022-09-01
Primary completion
2023-06-30
Completion
2023-07-31
First posted
2024-05-31
Last updated
2024-07-29

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06437262. Inclusion in this directory is not an endorsement.